Comparison of the Everolimus Eluting (XIENCE-V® or PROMUS® Stent) With the Biolimus A9 Eluting NOBORI® Stent in All-comers: a Randomized Open Label Study The COMPARE II Trial Imaging and Vasomotion Substudy
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Everolimus (Primary) ; Umirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms COMPARE-IT
- 19 Dec 2016 New trial record